New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 13, 2014
07:06 EDTMDCOThe Medicines Co. downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse downgraded The Medicines Co. following the surprisingly negative cangrelor FDA panel. The firm said the setback removes and important value driver and now sees limited outperformance for shares. Price target lowered to $35 from $45.
News For MDCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 24, 2014
06:14 EDTMDCOThe Medicines Co. to host investor and analyst meeting
Infectious Disease Care Investor and Analyst Meeting will be held on September 24 at 8:30 am. There will be a conference call hookup and webcast available. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use